Reoperations for @entity0 predispose to a higher risk of @entity6081 than primary procedures. We accomplished a retrospective chart review of 320 @entity1 who underwent multiple @entity0 procedures between 10/97 and 8/02. The mean number of procedures was 2.4 (range, 2-5). The overall incidence of @entity2737 was 6.1 per cent. @entity2737 developed, on average, 12 days after surgery (range, 2-30). There was a statistically significant difference in the incidence of @entity2737 comparing the initial procedure versus the subsequent operation (1.6% vs. 9.4%, P < 0.001). This was also seen with reoperation after an operative biopsy compared to operation after a core biopsy (11.1% vs. 9.7%, P < 0.01). The incidence was increased to 22.0 per cent when the initial operation involved lymph node dissection (sentinel lymph node biopsy or complete axillary lymph node dissection). Wire localization did not increase the incidence of @entity6081 , and prophylactic antibiotics were associated with a decreased incidence of @entity2737 in the reoperative setting. The incidence of @entity2737 is increased with reoperation after operative biopsy compared to operation after core biopsy and is further increased when the initial biopsy involved lymph node dissection.

Does reoperation predispose to @entity6081 in @entity1 undergoing operation for XXXX ?

@entity1 :: ('9606', 'Species') :: ['women'] @entity6081 :: ('MESH:D013530', 'Disease') :: ['postoperative wound infections'] @entity0 :: ('MESH:D001943', 'Disease') :: ['breast cancer'] @entity2737 :: ('MESH:D014946', 'Disease') :: ['Wound infections', 'wound infection']
@entity0 :: (MESH:D001943,Disease) :: ['breast cancer']
